A phase 3 trial has found that a weekly injection called retatrutide helps manage type 2 diabetes by mimicking three gut hormones to control appetite, blood sugar, and metabolism. Participants saw significant improvements in weight loss and blood sugar levels compared to a placebo, offering a new potential treatment option for those managing the condition.